Guerbet AG is a Originators company based in Zürich (Zurich) recorded by Swissmedic as the authorisation holder for 11 human medicines. That places it 138 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Synthetika.
Key facts
| Sector | Originators |
|---|---|
| City | Zürich |
| Canton | Zurich |
| Authorisation holder | Yes |
| Medicines | 11 |
| Founded | 1987 |
| Employees | 11-50 |
| Parent group | Guerbet SA |
| Activity | Not available |
| Website | guerbet.com |
Medicines authorised in Switzerland
Guerbet AG is recorded by Swissmedic as the authorisation holder for 11 human medicines. The table shows 11 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
11 of 11 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Artirem | 56123 | B | V08CA02 | 2002-09-25 |
| Dotarem | 49784 | B | V08CA02 | 1990-06-28 |
| Elucirem 0.5 mmol/ml | 68791 | B | V08CA12 | 2023-12-21 |
| Elucirem 0.5 mmol/ml | 69037 | B | V08CA12 | 2023-12-21 |
| Lipiodol Ultra-fluide | 30274 | B | V08AD01 | 1964-09-24 |
| Micropaque | 30241 | B | V08BA01 | 1964-02-17 |
| Micropaque Scanner | 50151 | B | V08BA01 | 1989-11-10 |
| Optiray 300 | 49999 | B | V08AB07 | 1990-07-18 |
| Patentblau V Guerbet | 56517 | B | V04CX09 | 2010-02-12 |
| Telebrix Gastro | 49508 | B | V08AA05 | 1988-10-18 |
| Xenetix 300 mg | 53001 | B | V08AB11 | 1995-08-29 |
Frequently asked questions
How many medicines does Guerbet AG have authorised in Switzerland?
Guerbet AG is recorded by Swissmedic as the authorisation holder for 11 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is Guerbet AG based?
The Swiss location recorded for Guerbet AG is Zürich, Zurich.
Is Guerbet AG a Swissmedic authorisation holder?
Yes. Guerbet AG appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.